What is CPMD stock price today?

CPMD (CannaPharmaRx Inc) stock is trading at $0.00 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is CPMD stock going up or down today?

CPMD stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy CPMD stock now?

The decision to buy CPMD depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is CPMD a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for CPMD based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is CPMD stock overvalued or undervalued?

Use our DCF valuation calculator to determine if CPMD is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is CPMD's P/E ratio?

P/E ratio data for CPMD will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is CPMD's market cap?

CPMD (CannaPharmaRx Inc) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is CPMD's price to book ratio?

CPMD trades at a price-to-book (P/B) ratio of 11.05, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does CPMD pay dividends?

CPMD does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is CPMD's dividend yield?

CPMD does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is CPMD stock a good long-term investment?

CPMD's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is CPMD's revenue growth rate?

CPMD has shown revenue growth of 0.9% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Profitability metrics for CPMD are available on our dashboard with complete income statement analysis.

What are the risks of investing in CPMD?

Key risks for CPMD include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does CPMD compare to its competitors?

Compare CPMD to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize CPMD's performance and positioning.

What is CPMD's stock price target for 2026?

Our AI model provides price targets for CPMD based on fundamental analysis: Bull case $0.00 (+30%), Base case $0.00 (+15%), Bear case $0.00 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about CPMD?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for CPMD. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is CPMD's next earnings report?

CPMD reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

CPMD - CannaPharmaRx Inc

NYSE * Healthcare * Drug Manufacturers - Specialty & Generic

$0.00

+$0.00 (+0.00%)

About CannaPharmaRx Inc

CannaPharmaRX, Inc. engages in acquisition, development, and operation of cannabis cultivation facilities in Germany, Israel, Portugal, and Canada. It produces and sells dried cannabis flower and trim shake, as well as unique genetics, medical cannabis, and craft products. The company is based in Cremona, Canada.

CPMD Key Statistics

Market Cap

$0.34M

P/B Ratio

11.05

EPS

$-0.02

Revenue Growth

+0.9%

Employees

How CPMD Compares to Peers

CPMD has the fastest revenue growth among competitors

CPMD is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
CPMD(This stock)	$339.25K	N/A	1%	0.0%	-
LLYEli Lilly	$1.00T	40.0	1%	0.3%	vs LLY
JNJJohnson &	$549.25B	26.5	0%	0.2%	vs JNJ
PFEPfizer Inc	$147.50B	19.8	0%	0.1%	vs PFE
MRKMerck &	$297.02B	33.9	0%	0.1%	vs MRK
ABBVAbbVie Inc	$383.62B	106.4	0%	0.1%	vs ABBV

CannaPharmaRx Inc Company Information

Headquarters: 4439 Township Rd 304, Cremona, AB, Canada, T0M 0R0, undefined
Website: www.cannapharmarx.com
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Data Updated: June 5, 2026 at 11:04 AM EDT

Ready to invest in CPMD?

Commission-free trading available. Affiliate links.

CPMD Lician Score

10% confidence

6.0/10

Good

CPMD has a Lician Score of 6/10 (Good). Strengths: Growth.

value

5.0

growth

7.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates CPMDacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

CPMD Financial Snowflake

5-axis analysis across key investment dimensions

5.4/10

Neutral

5.0

Value

Valuation vs. sector peers

7.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for CPMD

Dashboard

Enter a ticker to analyze